WASATCH ADVISORS INC 13D and 13G filings for Sangamo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-07 6:47 pm Sale |
2024-12-31 | 13G | Sangamo Therapeutics, Inc. SGMO |
WASATCH ADVISORS INC | 13,993,410 6.600% |
-10,900,819 (-43.79%) |
Filing |
| 2024-04-05 3:59 pm Purchase |
2024-04-05 | 13G | Sangamo Therapeutics, Inc. SGMO |
WASATCH ADVISORS INC | 24,894,229 11.900% |
12,496,305 (+100.79%) |
Filing |
| 2024-02-09 12:17 pm Sale |
2024-02-09 | 13G | Sangamo Therapeutics, Inc. SGMO |
WASATCH ADVISORS INC | 12,397,924 7.000% |
-5,588,857 (-31.07%) |
Filing |
| 2023-10-10 3:09 pm Purchase |
2023-10-10 | 13G | Sangamo Therapeutics, Inc. SGMO |
WASATCH ADVISORS INC | 17,986,781 10.160% |
5,336,027 (+42.18%) |
Filing |
| 2023-02-09 4:21 pm Purchase |
2023-02-09 | 13G | Sangamo Therapeutics, Inc. SGMO |
WASATCH ADVISORS INC | 12,650,754 7.700% |
1,689,772 (+15.42%) |
Filing |
| 2022-02-10 5:42 pm Purchase |
2022-02-11 | 13G | Sangamo Therapeutics, Inc. SGMO |
WASATCH ADVISORS INC | 10,960,982 7.500% |
888,601 (+8.82%) |
Filing |
| 2021-02-11 2:09 pm Purchase |
2021-02-11 | 13G | Sangamo Therapeutics, Inc. SGMO |
WASATCH ADVISORS INC | 10,072,381 7.100% |
2,585,364 (+34.53%) |
Filing |